Zai Lab Limited ZLAB

TheHermitTrader_ Premium

$ZLAB - Hot sector: China and biotechs - Building tight flag above 10 DMA - Low cheat below $50 pivot of larger base

succes Pro+

I consider that at 22.62 the down trend has all the chances to have ended and it is possible to go up in a new upward trend

itssean310

$ZLAB is a Chinese biotech company specializing in the treatment of cancer, among other things. In December an insider bought 4,000 shares. Also, hedge funds have been increasing their exposure to $ZLAB for the last 4 quarters. The stop is 7% below at the red line. There are 2 upper trend lines (yellow). My feeling is that $ZLAB will be unsuccessful at getting...

RocketTickers

ZLAB,ETTX: Zai Lab Limited 2021-10-19 09:00:00 Zai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK Trial

06:58

CobraTrader13

My Watchlist: $JNCE $SRNE $SURF $UBX $BNTX $ZLAB $ATOS The bio market is getting hot again! Like and follow for more biotech ideas :) Happy Trading!

00:00

CobraTrader13

My biotech watchlist for this week: FDA Hype $GLYC $AGEN $GLSI $ONCY $MTEM $ALPN $ALPN $CMPI $ATXI Potential Swings $CTXR $UBX $ZLAB Like and follow for weekly bio watchlists :) Also please comment your favorite tickers; I would love to hear what you guys think. Happy Trading!

Investor4321 Pro

Zai Lab has partnered with Five Prime Therapuetics in the making and testing of the cancer treatment drug FPA144 + chemo (FIGHT). The stock is projected to rise 20+% on Friday, January 15, when the data is released. The data will be released 10:00-11:15 EST. Like and Follow if you want to see more trades like this.

RocketTickers

ZLAB,MGNX: Zai Lab Limited 2020-12-16 20:15:08 Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer

RocketTickers

ZLAB: Zai Lab Limited 2020-05-28 07:37:40 Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer

TheBullseye Pro+

After hit the pivot resistance, $ZLAB is pulling back to the support zone. It will most likely form a handle. If it breaks out $63.95, the pattern will be confirmed.

diegocede Pro

Long

denisf1

next week ideas

OPTIONSHAWK Premium

ZLAB an intriguing name, saw strong accumulation opening month of year and has rested

alipipefitter Updated 

Secondary offering of 7.5 million shares at $20 per share. Sell $20.00ish I think the overreaction is due to investors starting to tighten up the belt due to market conditions. Again, this is just a quick swing off this full retracement. This just seems a bit overly reactionary to me. Stop 10%